Sales & Earnings In Brief

“The Tan Sheet” Feb. 20, 2012, Vol. 20, No. 08
Sales & Earnings / Word Count: 493 / Article # 05120220026

Executive Summary

GNC passes $2B in annual revenue; launches lift Watson earnings; NAI benefits from FDA supplement crackdown; PuraMed turns corner with LipiGesic M product rollout.

Purchase this Article

$35.00 Buy Now

For $35.00, purchase this 493-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

+ Show All | – Hide All

There are no current related articles

Offers & Events

Topics Covered in this Article

Click a keyword for related articles.
General Topics
Nutritional products
OTC drugs
Quarterly earnings
Subjects
Business Strategies
Financial Strategies
Industries
Consumer Products
Regions
North America
Companies
Watson Pharmaceuticals Inc.
Rugby Laboratories Inc.
Natural Alternatives International Inc.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: Sales & Earnings In Brief

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to “The Tan Sheet” will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel